AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS

Jedinjenje predstavljeno strukturom sa Formulom (I):pri čemuR je COOH;i njegove farmaceutski prihvatljive soli.Prijava sadrži još 22 patentna zahteva. The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WEBB, YAEL, YAN, JIAMING, VILLENEUVE, NICOLE, BELVEDERE, SANDRO, BERTRAND, MARC
Format:	Patent
Sprache:	eng ; srp
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Jedinjenje predstavljeno strukturom sa Formulom (I):pri čemuR je COOH;i njegove farmaceutski prihvatljive soli.Prijava sadrži još 22 patentna zahteva. The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.